Case Control Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Apr 28, 2016; 22(16): 4160-4167
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4160
Table 1 Etiology of chronic pancreatitis among patients who underwent intrathecal narcotic pump or total pancreatectomy + islet cell transplantation n (%)
IdiopathicPancreatic divisumAlcohol inducedGallstone inducedAuto-immune
ITNP group6/13 (46.1)3/13 (23.1)1/13 (7.7)2/13 (15.4)1/13 (7.7)
TP + ICT group19/30 (63.3)5/30 (16.7)4/30 (13.3)2/30 (6.7)0/30 (0)
Table 2 Multiple interventions performed in patients with chronic pancreatitis for pain control before undergoing intrathecal narcotic pump or total pancreatectomy + islet cell transplantation n (%)
ERCP with sphincterotomyCeliac Block (EUS or CT)Jejunal or Gastro-Jejunal tube insertionSurgeries (denervation or decompression)
ITNP group13/13 (100)6/13 (46)8/13 (61)8/13 (61)
TP + ICT group30/30 (100)15/30 (50)10/30 (33)10/30 (33)
Table 3 Status of insulin-dependent diabetes among all surgical patients before and after total pancreatectomy with islet cell transplantation
Number of patients with insulin independenceAverage dose of insulin/day (units)Average HbA1c
Before TP + ICT30/30 (100%)0N/A
After TP + ICT4/27 (approximately 15%)257.35%
Table 4 Summary of outcomes among patients with intrathecal narcotic pump and those with total pancreatectomy and islet cell transplantation
ITNPTP + ICTComparison
Reversibility of the procedureYesNoDifferent
Success rate for pain control77%80%Similar
Residual narcotic dose usage (mg equivalent of oral morphine sulfate)Mean = 158 mg/dMean = 104 mg/dSimilar
Median = 8 mg/dMedian = 40 mg/d
Percentage of patients with poor pain control16.7%11.1%Similar
Percentage of patients with new insulin dependent diabetes0%Approximately 85%Different
Procedure related death0%10%Different